Insights into the pharmacological potential of estrogens and phytoestrogens on catecholamine signaling

Annals of the New York Academy of Sciences

Volumn 1129, Issue , 2008, Pages 96-104

  Yanagihara, Nobuyuki ^a   Toyohira, Yumiko ^a   Shinohara, Yuko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adrenal medulla; Catecholamine synthesis and secretion; ERK; Estrogens; Membrane estrogen receptor; Phytoestrogen

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CATECHOLAMINE; DAIDZEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; PHYTOESTROGEN; RESVERATROL; TYROSINE 3 MONOOXYGENASE; ISOFLAVONE DERIVATIVE; PROTECTIVE AGENT; STILBENE DERIVATIVE;

ADRENAL CELL; BEHAVIOR; BINDING SITE; BLOOD LEVEL; CATECHOLAMINE NERVE CELL; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CELL ACTIVITY; CELL FUNCTION; CELL MEMBRANE; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; HEART PROTECTION; HORMONE ACTION; HORMONE BINDING; NERVE CONDUCTION; NEUROPHARMACOLOGY; NONHUMAN; PHARMACODYNAMICS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; CARDIOVASCULAR SYSTEM; CATTLE; CELL CULTURE; DOSE RESPONSE; INTRACELLULAR SPACE; METABOLISM; SIGNAL TRANSDUCTION;

BOVINAE; VITACEAE;

ANIMALS; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CATTLE; CELL MEMBRANE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; INTRACELLULAR SPACE; ISOFLAVONES; MODELS, BIOLOGICAL; PHYTOESTROGENS; PROTECTIVE AGENTS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STILBENES;

EID: 47249148379     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1417.008     Document Type: Conference Paper

References (53)

1. Green, G.L., P. Gilna, M. Waterfield, et al. 1986. Sequence and expression of human estrogen receptor complementary DNA. Science 231 : 1150 1154.
2. Krust, A., S. Green, P. Argos, et al. 1986. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J. 5 : 891 897.
3. Wehling, M. 1997. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59 : 365 393.
4. Falkenstein, E., H.-C. Tillmann, M. Christ, et al. 2000. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 52 : 513 556.
5. 45Ca influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience 15 : 283 292.
6. 2-adrenergic agonists on carbachol-stimulated catecholamine synthesis in cultured bovine adrenal medullary cells. Biochem. Pharmacol. 36 : 3823 3828.
7. Nagatsu, T., M. Levitt & S. Udenfriend. 1964. Tyrosine hydroxylase. the initial step in norepinephrine biosynthesis. J. Biol. Chem. 239 : 2910 2917.
8. Dunkley, P.R., L. Bobrovskaya, E. Mark, et al. 2004. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 91 : 1025 1043.
9. Nagamoto-Combs, K., K.M. Piech, J.A. Best, et al. 1997. Tyrosine hydroxylase gene promoter activity is regulated by both cyclic AMP-responsive element and AP1 sites following calcium influx. Evidence for cyclic amp-responsive element binding protein-independent regulation. J. Biol. Chem. 272 : 6051 6058.
10. + in PC12 cells in culture. Mol. Pharmacol. 26 : 141 147.
11. Terao, T., N. Yanagihara, K. Abe, et al. 1992. Lithium chloride stimulates catecholamine synthesis and secretion in cultured bovine adrenal medullary cells. Biol. Psychiatry 31 : 1038 1049.
12. Yoshimura, R., N. Yanagihara, K. Hara, et al. 2001. Dual phases of functional changes in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine. J. Neurochem. 77 : 1018 1026.
13. Shinkai, K., Y. Toyohira, R. Yoshimura, et al. 2007. Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran. Naunyn-Schmiedeberg's Arch. Pharmacol. 375 : 65 72.
14. Serova, L., M. Rivkin, A. Nakashima, et al. 2002. Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. Neuroendocrinology 75 : 193 200.
15. Arbogast, L.A. & J.F. Hyde. 2000. Estradiol attenuates the forskolin-induced increase in hypothalamic tyrosine hydroxylase activity. Neuroendocrinology 71 : 219 227.
16. Tseng, J.Y., P.E. Kolb, M.A. Raskind, et al. 1997. Estrogen regulates galanin but not tyrosine hydroxylase gene expression in the rat locus coeruleus. Brain. Res. Mol. Brain. Res. 50 : 100 106.
17. Yanagihara, N., Y. Toyohira, S. Ueno, et al. 2005. Stimulation of catecholamine synthesis by environmental estrogenic pollutants. Endocrinology 146 : 265 272.
18. Toyohira, Y., K. Utsunomiya, S. Ueno, et al. 2003. Inhibition of the norepinephrine transporter function in cultured bovine adrenal medullary cells by bisphenol A. Biochem. Pharmacol. 65 : 2049 2054.
19. Hall, J.M., J.F. Couse & K.S. Korach. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276 : 36869 36872.
20. Improta-Brears, T., A.R. Whorton, F. Codazzi, et al. 1999. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 96 : 4686 4691.
21. Aronica, S.M., W.L. Kraus & B.S. Katzenellenbogen. 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91 : 8517 8521.
22. Meligeni, J.A., J.W. Haycock & W.F. Bennett. 1982. Phosphorylation and activation of tyrosine hydroxylase mediate the cAMP-induced increase in catecholamine biosynthesis in adrenal chromaffin cells. J. Biol. Chem. 257 : 12632 12640.
23. Halloran, S.M. & P.R. Vulliet. 1994. Microtubule-associated protein kinase-2 phosphorylates and activates tyrosine hydroxylase following depolarization of bovine adrenal chromaffin cells. J. Biol. Chem. 269 : 30960 30965.
24. Norfleet, A.M., C.H. Clarke, B. Gametchu, et al. 2000. Antibodies to the estrogen receptor-a modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J. 14 : 157 165.
25. Toran-Allerand, C.D., X. Guan, N.J. MacLusky, et al. 2002. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22 : 8391 8401.
26. Carmeci, C., D.A. Thompson, H.Z. Ring, et al. 1997. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45 : 607 617.
27. Thomas, P., Y. Pang, E.J. Filardo, et al. 2005. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 : 624 632.
28. Falkenstein, E., H.-C. Tillmann, M. Christ, et al. 2000. Multiple actions of steroid hormones - A focus on rapid, nongenomic effects. Pharmacol. Rev. 52 : 513 555.
29. Renaud, S. & M. de Lorgeril. 1992. Wine, alcohol, platelets, and the French Paradox for coronary heart disease. Lancet 339 : 1523 1526.
30. Hung, L.M., J.K. Chen, S.S. Huang, et al. 2000. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 : 549 555.
31. Andriambeloson, E., L.A. Kleschyov, B. Muller, et al. 1997. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br. J. Pharmacol. 120 : 1053 1058.
32. Pace-Asciak, C.R., O. Rounova, S.E. Hahn, et al. 1996. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta. 246 : 163 182.
33. Bastianetto, S., W.H. Zheng & R. Quirion. 2000. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 131 : 711 720.
34. Leonard, S.S., C. Xia, B.H. Jiang, et al. 2003. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 309 : 1017 1026.
35. Cassidy, A. & B. Griffin. 1999. Phyto-oestrogens: a potential role in the prevention of CHD? Proc. Nutr. Soc. 58 : 193 199.
36. Upmalis, D.H., R. Lobo, L. Bradley, et al. 2000. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7 : 236 242.
37. Wong, W.W., E.O. Smith, J.E. Stuff, et al. 1998. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am. J. Clin. Nutr. 68 : 1385S 1389S.
38. Lichtenstein, A.H. 1998. Soy protein, isoflavones and cardiovascular disease risk. J. Nutr. 128 : 1589 1592.
39. Westfall, T.C. & D.P. Westfall. 2005. Adrenergic agonists and antagonists. In Goodman & Gilman the Pharmacological Basis of Therapeutics. 11th ed. L.L. Brunton, J.S. Lazo & K.L. Parker, Eds 237 295. McGraw-Hill. New York.
40. Lymperopoulos, A., G. Rengo, H. Funakoshi, et al. 2007. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat. Med. 13 : 315 323.
41. Morton, M.S., O. Arisaka, N. Miyake, et al. 2002. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J. Nutr. 132 : 3168 3171.
42. Xu, X., K.S. Harris, H.J. Wang, et al. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125 : 2307 2315.
43. Goldberg, D.M., E. Tsang, A. Karumanchiri, et al. 1996. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem. 68 : 1688 1694.
44. Manach, C., A. Scalbert, C. Morand, et al. 2004. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 : 727 747.
45. Fink, G., B.E.H. Sumner, R. Rosie, et al. 1996. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 16 : 325 344.
46. Weinstock, L.S. 1999. Gender differences in the presentation and management of social anxiety disorder. J. Clin. Psychiatry 60 : 9 13.
47. Joffe, H. & L.S. Cohen. 1998. A decade of serotonin research: regulation of affect and eating behavior: estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol. Psychol. 44 : 798 811.
48. Klaiber, E.L., D.M. Broverman, W. Vogel, et al. 1979. Estrogen therapy for severe persistent depression in women. Arch. Gen. Psychiatry 36 : 550 554.
49. Grenngrass, P.M. & S.R. Tonge. 1974. The accumulation of noradrenaline and 5-hydroxytryptamine in three regions of mouse brain after tetrabenazine and iproniazide: effects of ethinyloestradiol and progesterone. Psychopharmacology 39 : 187 191.
50. Nagel, S.C., F.S. vom Saal & M.V. Welshons. 1998. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc. Soc. Exp. Biol. Med. 217 : 300 309.
51. Sun, Y., M.N. Nakashima, M. Takahashi, et al. 2002. Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 16 : 319 326.
52. Suzuki, T., K. Mizuo, H. Nakazawa, et al. 2003. Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 117 : 639 644.
53. Kubo, K., O. Arai, R. Ogata, et al. 2001. Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci. Lett. 304 : 73 76.